Introduction
Approximately one-third of the adult population in the United States is now overweight or obese (1) , and obesity is associated with increased risk for many diseases, including heart disease, diabetes, hypertension, and cancer. The evidence for a genetic basis for obesity is compelling (2) (3) (4) (5) (6) (7) , and an understanding of the pathways regulating body mass and body composition is beginning to emerge. Single gene mutation mouse models of obesity have been particularly informative and have led to the identification of leptin and other proteins controlling body fat stores (8) (9) (10) (11) (12) (13) . Nevertheless, the genetic factors contributing to differences in susceptibility to obesity in human populations remain largely unknown. Human obesity is multifactorial, with important environmental influences as well as multiple genetic factors, making analysis of the genetic contributions difficult.
The dissection of complex traits into their underlying genetic elements has begun for a number of diseases, using both human and animal populations (14) (15) (16) (17) . One method for identifying genetic loci that contribute to complex traits in animals is quantitative trait locus (QTL) 1 mapping, which involves interbreeding two strains of mice which differ in the phenotype of interest for two generations to produce F2 mice. Each of these F2 mice represents a genetically unique combination of parental genes and phenotypes. The genome is then tested for the parental origin of the genetic elements, using polymorphic genetic markers in a whole-genome scan. Finally, statistical association of the inheritance of particular parental traits with unique genetic elements identifies loci which contain genes affecting these traits. These loci are broad, encompassing distances of 15-30 cM. Resolution is limited by the number of genetic recombinations represented in the population examined, and, unlike simple Mendelian traits, a multigenic phenotype may require the coinheritance of minor genetic elements for the effect of the major locus to be seen.
A genetic locus can be isolated from other genes controlling the trait by incorporating a small chromosomal segment containing the gene of interest from one mouse strain onto the genome of a second mouse strain by selective breeding to create a congenic strain (18) (19) (20) (21) . Thus, comparison of a phenotype of a congenic strain with the phenotype of its background strain allows study of the effects of single genes derived from the donor strain, isolated from the effects of other donor strain genes. The isolation of more than 40 minor histocompatibility genes (22) and the recent production of congenic mouse strains isolating epilepsy QTLs (23), nonobese diabetic mousederived diabetogenic genetic intervals (20) , and SLE-susceptibility genes (21) demonstrate the feasibility of using congenic strains to dissect the complex pathogenic mechanisms of polygenic disease.
Because of the evolutionary relationship between mice and humans, many ancestral chromosomal segments have been conserved, where the same genes occur in the same order within discrete regions. Chromosomal rearrangements have placed these syntenic regions on different chromosomes; however, maps of linkage and synteny homologies between mice and humans (24) make it relatively straightforward to test in humans the candidate loci found in mouse studies. Mouse/human synteny relationships have been recently summarized by DeBry and Seldin (25) (http://www.ncbi.nlm.nih.gov/Omim/ Homology/). Homologues of single genes that cause obesity in rodents were examined in several human populations with both positive (26, 27 ) and negative (28-30) results.
We report here the use of a whole-genome search in a mouse cross to identify a gene contributing to multigenic obesity on distal mouse chromosome 2. This locus was subsequently confirmed in a congenic mouse strain. Examination of the homologous region in adult sibships from the Quebec Family Study shows that a locus on human chromosome 20q contributes to body fat and insulin in a human population, and demonstrates the utility of using interspecies syntenic relationships to find relevant disease loci in humans.
Methods
Mouse studies. NZB/BINJ and SM/J mice were purchased from The Jackson Laboratory (Bar Harbor, ME). NZB/BINJ females were mated with SM/J males to produce F1 progeny, which were brothersister mated to produce F2 intercross mice. The NZB/BINJ ϫ SM/J cross was initially set up to study genetic factors in lipoprotein metabolism, and a complete description of the cross and the lipoproteins in these mice was reported previously (31) . 84 female 21-d-old F2 mice were weaned onto rodent chow containing 12% calories as fat (Purina 5001; Ralston Purina, St. Louis, MO), then at 3-5 mo were fed an atherogenic diet containing 30% calories as fat (Teklad 90221; Teklad Premier Laboratory Diets, Madison, WI) for 15 wk. Chromosome 2 congenic mice, B10.LP/SnJ (H3, H13), and the corresponding background strain, C57BL/10SnJ, were also purchased from The Jackson Laboratory. The congenic and background mice ( n ϭ 5 mice per group) were fed rodent chow (Purina 5001; Ralston Purina) until time of killing at 8 mo. The mice were housed and cared for under conditions meeting AAALAC accreditation standards. All mice were caged individually and given free access to food and water. A 12-h light-dark cycle was maintained throughout the experiment.
Quantitative phenotyping and genotyping of microsatellite markers were done as previously described (31, 32) . Mice were fasted ‫ف‬ 15 h before collection of blood and time of killing at 3 h into the light phase of the diurnal cycle. The mice were anesthetized using isoflurane and killed by cervical dislocation. Blood samples were collected from the retroorbital sinus in plasma separator tubes containing EDTA, placed on ice, and centrifuged to prepare plasma. Plasma insulin was determined in congenic and background mice by RIA using a kit incorporating a rat insulin standard (ICN Biomedicals, Inc., Costa Mesa, CA). Kidneys, liver, and spleen were collected for DNA isolation. In congenic and background mice, four fat pads consisting of three intraabdominal fat pads, the retroperitoneal, mesenteric, and gonadal fat pads, and the femoral fat pad, which is a subcutaneous fat pad on the outer thigh, were dissected, weighed, and returned to the carcass. Body composition was based on the carcass remaining after removal of the liver, kidneys, and spleen. The carcass was dried to constant weight at 90 Њ C, homogenized, and aliquots taken for extraction of lipid in a Soxhlet apparatus. Carcass water and lipid were determined gravimetrically. 84 female mice were analyzed in the F2 intercross. Five female congenic mice and five female background mice were analyzed in the congenic test.
All genotyping proceeded by PCR amplification of microsatellite markers. PCR primers for microsatellite markers were purchased from Research Genetics (Huntsville, AL), and are listed in the figures according to their commercial names. PCR was performed using mouse DNA at a concentration of 2 ng/ l in a volume of 10 l. The 32 P-labeled primers were allowed to anneal at 53 Њ C and extend at 72 Њ C for 25 cycles. The PCR products were visualized by running them on 5% acrylamide denaturing gels, and exposing the dried gels to x-ray film.
ANOVA and regression analysis were done using the Statview 4 statistical program for the Macintosh computer (Abacus Concepts, Inc., Berkeley, CA), while the linkage map and likelihood of the odds (LOD) scores for QTL mapping of the intercross were calculated using the MAPMAKER/QTL program (provided by S. Lincoln and E. Lander, Whitehead Institute for Biomedical Research, Cambridge, MA). An LOD score of 4.3 or greater was considered statistically significant evidence of association in intercross mice (33) . The data were adjusted for the effects of age by regression analysis.
Human studies. Selection criteria and the phenotypes measured in the Quebec Family Study have been described previously (34) . Quantitation of various measures pertaining to obesity was performed in 650 individuals (351 females and 299 males) from 152 pedigrees during a 1-d visit of the families to the laboratory. Measures included body mass index (BMI ϭ weight in kilograms divided by height in squared meters), percent fat, and subcutaneous fat. Body density was measured by the underwater weighing procedure, and percentage of body fat was computed from the estimate of body density using the Siri equation (35). Fat mass and fat-free mass were computed from percent body fat and body mass. The amount of subcutaneous fat was assessed by summing skinfold thickness (in millimeters) measured at six sites (abdominal, suprailiac, subscapular, medial calf, tricep, and bicep) on the left side of the body with a Harpenden skinfold caliper (Quinton #03496-001; Quinton Instrument Co., Seattle, WA 98121-2791), following the procedures recommended by the International Biological Programme (36) . Serum insulin was determined by RIA (37) in fasting subjects. These quantitative traits were adjusted by multiple regression procedures for the effects of age and sex, and standardized. Informed consent was obtained from all subjects after the nature and possible consequences of the study were explained.
All genotyping, with the exception of the melanocortin receptor 3 gene ( MC3R ) marker, was performed by PCR amplification of microsatellite markers, which are listed in the figures and tables according to their commercial names. PCR primers were obtained from Research Genetics except for the marker for the adenosine deaminase gene ( ADA ), which was constructed as described (38) . PCR was performed using human DNA at a concentration of 10 ng/ l in a volume of 5 l. The 32 P-labeled primers were allowed to anneal at 58 Њ C and extend at 72 Њ C for 25 cycles. The PCR products were visualized by running them on 5% acrylamide denaturing gels, and exposing the dried gels to x-ray film. The alleles were numbered and identified consistently across families.
RFLP typing of MC3R was performed using PstI digestion of 5 g DNA (New England Biolabs Ltd., Mississiauga, Ontario, Canada). The sizes of the resultant allelic fragments were 4.4 and 3.3 kb, measured by electrophoresis using DNA digested with EcoRI and HindIII as standards. The alleles were detected by Southern blot analysis, using a 1.1-kb MC3R probe labeled with 32 P by random priming, and exposing the blots to Kodak XAR-5 film (Eastman Kodak Co., Rochester, NY) with intensifying screens for 72-120 h at Ϫ 70 Њ C.
Linkage analysis was performed using the single locus sib-pair linkage method (39) . The sib-pair method has the advantage of being a nonparametric method of linkage analysis that requires no a priori knowledge of the mode of inheritance of the phenotype under investigation. The rationale underlying this method is that, in the presence of linkage between a marker locus influencing the quantitative trait, sib pairs sharing a greater proportion of genes (alleles) identical by descent (i.b.d.) at the marker locus will tend to have more similar phenotypes than sib pairs sharing fewer alleles. A negative relationship between the number of alleles shared i.b.d. and within sibship variance is therefore expected under the presence of linkage. Sib-pair analysis was performed using the program SIBPAL (version 2. 
Results
Linkage analysis in mice. 84 female F2 mice from a cross between NZB/BINJ and SM/J (31) were typed for measures of obesity and 126 genetic markers on all chromosomes except Y, with an average spacing of Ͻ 15 cM. Because the number of loci contributing to the variation in obesity in this cross is unknown, we chose to construct a map in which any gene would on average lie within 10 cM of a typed marker, so the power of detection of linkage would be maximized. The F2 mice ranged from 17.2 to 38.6 g (mean 24.2, SD 4.0) in weight, from 1.12 to 14.82 g (mean 4.48, SD 2.63) in fat mass, and from 6.0 to 38.4 (mean 17.6, SD 7.1) in percentage of body fat. We used the MAPMAKER/QTL program to find genetic loci (QTLs) underlying these traits. The distribution of these traits showed a right-sided skew towards higher values, and, although the untransformed data gave LOD scores of 3.5 or greater, a log transformation normalized the data and was used for subsequent analysis. The only locus in this cross showing significant linkage with obesity-related traits was found on mouse chromosome 2, bordered by markers D2Mit28 and D2Mit22. This locus showed linkage to percent body fat (LOD score 3.6), fat mass (LOD score 4.3), and body weight (LOD score 4.8) (Fig. 1 ). Variation at this locus explained 36% of the phenotypic variation in percent body fat in the NZB/BINJ ϫ SM/J cross. At this locus, no QTLs Ͼ 3 were found for triglycerides or FFA. As this cross was not constructed to study obesity, plasma insulin was not measured in the NZB/BINJ ϫ SM/J cross.
We reasoned that the genetic variations influencing obesity in the NZB/BINJ and SM/J cross may be relatively common, since many inbred strains of laboratory mice vary in body fat content and other traits related to obesity (40). Therefore, we examined a previously constructed congenic strain to determine the effect of this chromosomal locus on obesity in mice in the absence of the contributing effects of other genes. The congenic genome consists of DNA which is ‫ف‬ 98% identical to the background strain, with a small chromosomal segment donated by selective breeding from a second strain. Congenic strain B10.LP/SnJ consists of background strain C57BL/10SnJ, with a region containing the H3 and H13 histocompatibility loci on mouse chromosome 2 donated from strain LP/J. The borders of the donated region were mapped and lie ‫ف‬ 2 cM distal to Ada and 2 cM proximal to H3 (Fig. 2 A ) . When compared to the background strain, the congenic strain had a 7% decrease in body weight [congenic, 20.65 Ϯ 0.56 (standard error), background, 22.21 Ϯ 0.36, P Ͻ 0.0478], a 66% decrease in retroperitoneal fat pad weight (0.036 Ϯ 0.01, 0.106 Ϯ 0.01, P Ͻ 0.0019), a 35% lower percent body fat (9.73 Ϯ 1.0, 15.02 Ϯ 0.93, P Ͻ 0.0066), and 27% lower fasting plasma insulin (6.96 Ϯ 0.92, 9.56 Ϯ 1.59, P Ͻ 0.19) (Fig. 2 B ) . Plasma triglycerides did not differ in congenic and background mice. FFA were not measured. Together, analysis of the NZB/BINJ ϫ SM/J cross and comparison of the background and congenic strains demonstrate that distal mouse chromosome 2 contains a genetic locus with a substantial influence on body fat.
Linkage analysis in humans. To test whether the corresponding human chromosomal region contributes to multigenic obesity, subjects from the Quebec Family Study were examined. All of human chromosome 20 is homologous to the region of distal mouse chromosome 2 beginning with the gene Snrbp at 72 cM and extending to the gene Acra4 at 108 cM (25) . 11 markers within this region of chromosome 20 spanning a 52-cM region extending from approximately 20p12 to 20q13.3 were typed. Since earlier data from The Quebec Family Study indicated linkage of obesity to ADA isoforms (41), typing began with a marker within ADA and expanded in either direction. A maximum of 258 sib pairs (Table I) , of which 130 pairs (78 female, 52 male) were of the same sex and 128 pairs were of opposite sex, were studied. This population was characterized for the obesity-related phenotypes listed in Table II. The subjects varied from 18 to 94 yr in age and from 4 to 60% body fat.
Results of linkage analysis are presented in Fig. 3 . Suggestive evidence of linkage was observed between the percentage of body fat and the markers PLC1 (phospholipase C gene) ( P Ͻ 0.013), ADA ( P Ͻ 0.0079), D20S17 ( P Ͻ 0.0078), D20S120 ( P Ͻ 0.004), and MC3R ( P Ͻ 0.037). These results suggest the presence of two linkage peaks for percent body fat, one between PLC1 and D20S17 , and another ‫ف‬ 20-25 cM telomeric at D20S120 and MC3R (Fig. 3) . The reason for the absence of linkage at D20S197 and D20S176 is unclear, given the comparable heterozygosity of these markers. One possibility is that these peaks are not part of the same linkage group. We tested this possibility by using the proportion of alleles shared i.b.d. among siblings to determine linkage groups and to order loci (42) . This analysis indicated that these two peaks are actually part of the same linkage group. Another explanation is that there are two closely mapping genes which underlie percentage of body fat, although a total absence of linkage at markers between genes in close proximity is unlikely. Another possibil- Figure 1 . LOD plot for body weight, fat mass, and percent body fat adjusted for a linear effect of age, at the chromosome 2 locus in NZB/ BINJ ϫ SM/J intercross (F2) mice (31) . Phenotyping and genotyping were done as previously described (31, 32 ). The y axis shows the LOD score calculated by the MAPMAKER/QTL program (67) at 2-cM intervals. The x axis shows genetic distance of markers, calculated by the MAPMAKER program (67) as percent recombination (cM). All markers are linked to each other with log likelihood scores of at least 5. The order of these markers is supported by odds ratios of at least 100: 1. ity is that a small chromosomal inversion has occured within this population that has placed these two markers at the outer perimeter of the linkage group. Peak linkages for BMI, fat mass, and subcutaneous fat occurred at MC3R , with significance of P Ͻ 0.008, 0.011, and 0.017, respectively. The strongest linkage observed was to fasting insulin at MC3R ( P Ͻ 0.0005). Plasma triglycerides and FFA were not examined. It is noteworthy that this region of chromosome 20 does not exert any influence on lean body mass (fat-free mass) and appears to be specifically involved in determining adiposity and fasting insulin levels.
To remove the influence of outliers on the results, the distribution of standardized phenotypes was examined. Individuals with phenotype values beyond 3 SD from the mean were identified and set aside. There were eight outliers for BMI and subcutaneous fat, seven outliers for fasting insulin, six outliers for fat-free mass, five outliers for fat mass, and only one outlier for percent body fat. Linkage analyses were repeated without these individuals, and the results remained largely unchanged for percent body fat. For BMI and subcutaneous fat, the P values were slightly reduced but remained significant (P Ͻ 0.05). The linkage for fat mass shifted slightly distally (MC3R P Ͻ 0.046, D20S120 P Ͻ 0.016, D20S104 P Ͻ 0.011), but removal of outliers did not affect the linkage results in this region. However, the P value for linkage observed between fasting insulin and the MC3R marker went from 0.0005 to 0.03. Because the seven outliers for insulin could contribute to a real linkage with the marker for MC3R, we repeated the analysis for this phenotype by using a log 10 transformation of the data to reduce skewness, and kept the outliers in the analysis. With this Markers are listed in their relative genetic order, and the distance in centiMorgans is from the top of the short arm of chromosome 20. Sex-averaged recombination distances were derived from an integrated genetic and physical map available from the Genome Location Data Base (66) . All phenotypes were adjusted for age and sex. HZ, heterozygosity index. Subcut. fat, subcutaneous fat measured as the sum of six skinfolds.
transformation, the linkage observed remained significant (P Ͻ 0.0008). Therefore, we are confident that the linkages reported in Fig. 3 are not caused by extreme phenotypic values.
Discussion
This study used chromosomal synteny between the mouse model and humans to map a gene for obesity on human chromosome 20q. An initial whole-genome scan of the NZB/BINJ ϫ SM/J intercross progeny identified a single significant locus on distal mouse chromosome 2. The presence of an obesity gene on distal mouse chromosome 2 was confirmed using an unrelated congenic strain. As this region of mouse chromosome 2 is syntenic to human chromosome 20, we examined linkage between markers located within a 52-cM region extending from 20p12 to 20q13.3 and measures of obesity in French Canadian subjects. Sib-pair analysis of participants in the Quebec Family Study revealed suggestive linkages between percentage of body fat (P Ͻ 0.004) and fasting insulin (P Ͻ 0.0005), and a locus encompassing markers from ADA through MC3R. Suggestive linkages were also found for BMI (P Ͻ 0.008), subcutaneous fat (P Ͻ 0.017), and fat mass (P Ͻ 0.011), at MC3R. Although the mouse data predicted a locus affecting body composition in this region, the difference in fasting insulin in the congenic and background mice did not anticipate the very strong linkage seen in the humans. Because no insulin measurements were obtained in the intercross mice, it is unknown whether the chromosome 2 locus influenced insulin levels in these mice. Arguments have been made against the significance of reported linkages of the order of P ϭ 0.05 arising from a highdensity whole-genome scan (33) . Thus, P value thresholds of 7.4 ϫ 10 Ϫ4 have been recommended for suggestive linkage, and 2.2 ϫ 10 Ϫ5 for significant linkage, in humans using sib-pair analysis (33) . However, these guidelines may be too stringent when applied to the present data. In this study, both the QTL in the mouse cross and the difference between congenic and background strains suggested that the search be restricted to a 50-cM region of linked markers on human chromosome 20. Therefore, linkage at this site can be considered a true singlepoint test of significance rather than the result of a genomewide search. However, as the number of markers tested increases, the likelihood that linkage will be found purely by chance also increases. If the critical P value for 11 random marker tests is P ϭ 0.05/n, where n is the number of tests, then percentage of body fat at D20S120 and fasting insulin at MC3R still meet the critical cutoff of P ϭ 0.0045. Linkage with percentage of body fat at D20S120 remains even after the removal of outliers beyond 3 SDs. To further establish the stability of these results, we calculated the 95% confidence interval of the regression coefficient for the significant linkages, and found that for P values Ͻ 0.017, the coefficient of regression remains negative, suggesting that most of the linkages reported in Fig. 3 are significant. However, it is important to confirm these results in additional population samples.
Measurement of multiple phenotypes likewise may require adjustment of the significance level (33) . The Quebec Family Study data suggest that BMI and percent body fat likely share common genetic effects (i.e., pleiotropy), and that the bivariate heritability or common heritability between the two phenotypes is 10% (43) . Thus, it is likely that one gene or a set of genes influences all of the obesity phenotypes. Although BMI and percent body fat were well correlated within individuals, the covariation between these traits is not necessarily attributable to common genetic factors and may be rather the result of environmental factors specific to each individual. However, under the pleiotropy hypothesis, we assume that the correlation between BMI and percent fat is at least partly accounted for by genetic factors. Therefore, no Bonferroni correction of the P values to adjust for multiple obesity phenotypes was made (33) .
A complete linkage map of the mouse and human chromosomal regions examined is shown in Fig. 4 , where the introgressed region of the congenic mouse model as well as the 90% confidence interval for the mouse QTL are indicated. Given that the confidence interval for the QTL is not precise, the possible genes in the syntenic human region range from the agouti signaling protein gene (ASP) to the phosphoenolpyruvate carboxykinase gene (PCK1). There are several attractive candidate genes at this locus. Linkage for percent body fat occurred in the region of ADA (Fig. 3) , which has been suggested to be a possible candidate gene for obesity (41) . ADA is an ␣-adrenergic agonist with potent lipolytic and vasodilator effects which regulates both lipolysis and insulin sensitivity in human adipose tissue (44) (45) (46) . Thus, variations in ADA could theoretically explain the effects of this locus on both energy balance and insulin levels. Another candidate at this locus is the agouti gene, mutations of which result in ectopic expression of the normal agouti protein, resulting in yellow fur, obesity, and diabetes in mice (8, 11) . However, markers linked to the human homolog ASP showed no linkage to obesity in two prior studies (see below) (28, 29) . An attractive candidate for the human locus is MC3R, which is located on human chromosome 20q (47), 8 cM telomeric to D20S120, and is linked with percent fat, fat mass, subcutaneous fat, and plasma insulin in this study. MC3R is expressed in the hypothalamus, which is involved in neuroendocrine and autonomic control (48) . Melanocortin-3 receptors can be activated well by all members of the melanocortin family, including ␣-, ␤-and ␥-melanocyte-stimulating hormone and ACTH (49) . Since MC3R has been mapped in mice to ‫ف‬ 2 cM distal to D2Mit52 (50) , which maps distal to D2Mit227, MC3R appears to lie outside the congenic region of the B10.LP/SnJ mouse (see Fig. 2 A). However, MC3R remains a candidate for the QTL in the NZB/BINJ ϫ SM/J cross and in the human population. Another candidate, mapping to 20q13.3, is cytosolic PCK1 (51) . When the murine homologue of PCK1 is slightly overexpressed in transgenic rats, it leads to glucose intolerance and an increase in visceral adipose tissue in females (52) . It is possible that the locus represents an unknown gene. Evidence of linkage between various genetic markers and the amount of body fat in humans has been reviewed recently (53) . Only a few loci, identified by the use of the single locus sib-pair linkage method with a large number of sib pairs, show moderate to strong linkage (P Ͻ 0.005) with direct measures of body fat. One of them is the Kell blood group locus (7q33), which showed a strong linkage (P Ͻ 0.0001) with the amount of subcutaneous fat in 402 sib pairs from the Quebec Family Study (41) . More recently, another study on ‫ف‬ 250 sib pairs from the Quebec Family Study showed linkage between markers D1S200 and D1S476 on 1p32-p22, and fat mass (0.009 Ͻ P Ͻ 0.02) and subcutaneous fat (P Ͻ 0.02 at D1S476) (54) . In a different population, a marker (Tnfir24) located near TNF-␣ (6p21.3) was shown to be linked (P Ͻ 0.002) to percent body fat measured by underwater weighing in Pima Indians (55) . A single polymorphism was located in the promoter region of TNF-␣, but association could not be demonstrated between alleles at the polymorphism and percent body fat by these investigators.
Several studies have examined linkage of obesity to the genes which cause monogenic obesity in mice. Positive linkage of obesity measures to the obese gene was observed in French obese families (BMI Ͼ 35, P Ͻ 0.002) (26) , Mexican Americans (BMI, P Ͻ 0.003, trunkal skinfold thickness, P Ͻ 0.003, extremity skinfolds, P Ͻ 0.00014, waist circumference, P Ͻ 0.00063) (27), and an American population of extremely obese individuals (BMI Ͼ 40, P Ͻ 0.04) (56) . However, the obese gene was not linked to obesity, measured as BMI Ͼ 30, in a second population of Mexican Americans (30), nor to measures of obesity and energy metabolism in Pima Indians (29) . The single gene mutation, diabetes, and a QTL, dietary obese 1, map to the mid-portion of mouse chromosome 4, a region syntenic to human 1p31 and 1p35-p31. In adult sibships from the Quebec Family Study, suggestive linkages between markers on human 1p32-p22, and body fat and insulin have been reported recently with the strongest association found with fat mass (P ϭ 0.009) (54) . Also in the Quebec Family Study, positive linkage of BMI (P Ͻ 0.001) and skinfold thickness (P Ͻ 0.016) was found with plasma isoforms of the enzyme ADA (41), the gene for which maps to distal mouse chromosome 2, an area which shows striking linkage conservation with human chromosome 20, with identical gene order but expanded length in the human genome (25) . The agouti gene, several mutations of which cause obesity in mice (57), maps to this same region, although subsequent studies in other human populations did not find linkage of obesity and polymorphic DNA markers flanking the agouti locus (28, 29) . The linkage analyses in these different populations do not necessarily need to be consistent. It is possible for one population to have alleles of a gene at a locus which promote obesity, whereas those alleles could be too rare or too prevalent in a second population for detection of significant linkage. This may be the case in one population reporting negative results (29) .
Loci contributing to multigenic obesity, in addition to the one reported here, have been identified recently in humans through wide-genome searches for obesity genes. In one of these studies based on 660 markers spaced at an average of 8 cM and typed in 874 Pima Indians, two loci located on 11q21-q22 and 3p24.2-p22 showed significant linkage (P ϭ 0.001) with percent body fat (58) . In another study, 169 markers spaced at ‫ف‬ 20 cM were typed in 458 Mexican Americans, and a locus located on 2p21 showed evidence of linkage (LOD score 2.7) with fat mass (59) .
Results of this study based on syntenic mouse models demonstrate for the first time that a QTL on mouse chromosome 2/human chromosome 20 influences adiposity in humans. Several loci contributing to multigenic obesity, in addition to the one reported here, have been identified in various mouse models (32, [60] [61] [62] [63] . We chose to examine the human chromosome 20 locus, since the evidence in mice was particularly convincing, the region of synteny was clear, and since we previously found linkage of BMI and skinfold thickness with plasma isoforms of ADA, the gene for which maps to this region. It will be important to study in a similar manner additional loci identified in animal models. An earlier attempt to use this approach to identify the human homologue of an insulin-dependent diabetes mellitus-susceptibility gene first identified in the nonobese diabetic mouse model was not successful (64) . It has been argued that the ability of this method to detect human loci depends on the frequency of the alleles conferring susceptibility to a trait in the human population examined (65). However, more recently, using mouse/human synteny relationships to find linkage to obesity with the human homologue of the mouse diabetes gene (54) , and the mouse obese gene has been more successful (26, 27, 56) . In the appropriate population, such coordinated studies of the genetic control of obesity in both mice and humans should provide a powerful strategy for identifying the underlying causes of this significant public health problem.
